Health technology assessment in Australia: challenges ahead.

Suppr

超能文献

作者信息

Jackson Terri J

出版信息

Med J Aust. 2007 Sep 3;187(5):262-4. doi: 10.5694/j.1326-5377.2007.tb01238.x.

DOI:10.5694/j.1326-5377.2007.tb01238.x

PMID:17767428

Abstract

Australia is well placed to again lead the world in health technology assessment.

摘要

相似文献

Health technology assessment in Australia: challenges ahead.

Med J Aust. 2007 Sep 3;187(5):262-4. doi: 10.5694/j.1326-5377.2007.tb01238.x.

Confronting the "gray zones" of technology assessment: evaluating genetic testing services for public insurance coverage in Canada.

Int J Technol Assess Health Care. 2003 Spring;19(2):301-16. doi: 10.1017/s0266462303000278.

Antipodean assessment. Activities, actions, and achievements.

Int J Technol Assess Health Care. 2002 Spring;18(2):203-12. doi: 10.1017/s0266462302000223.

Health economics and health technology assessment: perspectives from Australia and New Zealand.

Crit Care Clin. 2012 Jan;28(1):125-33, vii. doi: 10.1016/j.ccc.2011.10.008.

The limited regulatory potential of medical technology assessment.

Va Law Rev. 1996 Nov;82(8):1525-1622.

Medicare and cost-effectiveness analysis.

N Engl J Med. 2005 Oct 6;353(14):1516-22. doi: 10.1056/NEJMsb050564.

Revolution then evolution: the advance of health economic evaluation in Australia.

Z Evid Fortbild Qual Gesundhwes. 2014;108(7):360-6. doi: 10.1016/j.zefq.2014.08.020. Epub 2014 Sep 20.

Assessing new health technologies: lessons to be learned from drugs.

Med J Aust. 1999 Nov 15;171(10):554-6. doi: 10.5694/j.1326-5377.1999.tb123795.x.

The role of NICE technology appraisal in NHS rationing.

Br Med Bull. 2007;81-82:51-64. doi: 10.1093/bmb/ldm007. Epub 2007 Apr 4.

Economic evaluation for pharmaceuticals in Germany.

Eur J Health Econ. 2007 Sep;8 Suppl 1:S1-2. doi: 10.1007/s10198-007-0066-1.

引用本文的文献

A pilot study to identify areas for further improvements in patient and public involvement in health technology assessments for medicines.

Patient. 2012;5(3):199-211. doi: 10.1007/BF03262492.

Societal values in the allocation of healthcare resources: is it all about the health gain?

Patient. 2011;4(4):207-25. doi: 10.2165/11588880-000000000-00000.

Health technology funding decision-making processes around the world: the same, yet different.

Pharmacoeconomics. 2011 Jun;29(6):475-95. doi: 10.2165/11586420-000000000-00000.

The use of economic evaluation in CAM: an introductory framework.

BMC Complement Altern Med. 2010 Nov 11;10:66. doi: 10.1186/1472-6882-10-66.

Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.

Pharmacoeconomics. 2009;27(11):931-45. doi: 10.2165/11314710-000000000-00000.

Cost-effectiveness of an intervention to reduce emergency re-admissions to hospital among older patients.

PLoS One. 2009 Oct 14;4(10):e7455. doi: 10.1371/journal.pone.0007455.

Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data.

Health Serv Res. 2008 Dec;43(6):1975-91. doi: 10.1111/j.1475-6773.2008.00887.x. Epub 2008 Aug 28.

Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices.

Aust New Zealand Health Policy. 2007 Oct 31;4:23. doi: 10.1186/1743-8462-4-23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验